TGA strengthens warnings for broad-spectrum antibiotics

More prominent warnings added to Product Information (PI) and Consumer Medicine Information (CMI) for all oral and injectable fluoroquinolones  Updated warnings regarding rare side effects are being added to PI and CMI for fluoroquinolones including ciprofloxacin, norfloxacin and moxifloxacin.  The Therapeutic Goods Administration (TGA) said the strengthened warnings would highlight side effects including:  Tremors, restlessness,